Top Markets
Coin of the day
Agentix Corp. Agentix Corp.

Agentix Corp.

AGTX
Rang in Aktien #38794
Agentix Corp., a company in the clinical development phase, specializes in the... Agentix Corp., a company in the clinical development phase, specializes in the discovery and commercialization of therapeutic agents aimed at treating metabolic disorders. Its pipeline includes two primary candidates: AGTX-2004, a peripherally-acting CB1 receptor antagonist, which has exhibited effectiveness in animal studies for both obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, also demonstrating positive results in animal models for obesity and non-alcoholic fatty liver diseases. The company was founded in 2013, initially known as FairWind Energy, Inc., before officially changing its name to Agentix Corp. in June 2019. Its operations are based in Dana Point, California.
Aktienkurs
$0.02
Zuletzt synchronisiert: 2026-08-13
Marktkapitalisierung
$801.34K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
-18.70%
Land
US
Handel Agentix Corp. (AGTX)

Kategorie

Dividendenrendite-Verlauf für Agentix Corp. (AGTX)
Dividendenrendite (TTM) von Agentix Corp. (Aktienkürzel: AGTX) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Agentix Corp. (AGTX) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber